A technician at a biotechnology firm checks a hydrolysis production process in Rongcheng, East China's Shandong Province on Tuesday. The firm's products are sold to more than 10 countries, formerly accounting for more than 75 percent of its orders. Amid the pandemic, it has actively transferred its emphasis to the domestic market, which now generates over 90 percent of its revenues. Photo: cnsphoto